Insulin glargine-lixisenatide Significantly Improves Blood Sugar Control in Insulin-Naive Adults with Type 2 Diabetes: Study Medha Baranwal12 March 2025 9:30 AM ISTUSA: A study published in Diabetes, Obesity and Metabolism found that insulin glargine-lixisenatide (iGlarLixi) significantly improves time-in-range...
Sanofi gets CDSCO Panel nod to study Antidiabetic Drug Insulin Glargine and Lixisenatide Injection Dr. Divya Colin1 March 2024 6:00 PM ISTNew Delhi: The drug major Sanofi has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
GLP-1 agonists may hasten progression of diabetic retinopathy Dr. Kamal Kant Kohli7 Aug 2023 11:30 AM ISTUSA: Studies have linked the use of GLP-1 receptor agonists with exacerbation of macular disease that frequently occurs in diabetes...
UK probes Novo Nordisk Ozempic, Saxenda over suicidal, self-harming thoughts Ruchika Sharma27 July 2023 2:30 PM ISTLondon: Britain is reviewing a class of drugs used in a diabetes medicine and a weight-loss treatment sold by Novo Nordisk after some patients...
Diabetes drug: Sanofi gets marketing authorization from CDSCO for Soliqua Ruchika Sharma28 March 2023 3:14 PM ISTSoliqua (10-40 and 30-60 prefilled pens) is a once-daily injectable combination drug containing insulin glargine 100 Units/ml, which is a long-acting...
Sanofi plea for Insulin Glargine, Lixisenatide antidiabetic combination rejected by CDSCO panel Medical Dialogues Team16 Sept 2021 4:14 PM ISTNew Delhi: In a major setback to Sanofi India Limited, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO)...
Lixisenatide addition to basal insulin helps achieve proper blood sugar control irrespective of BMI Dr Kartikeya Kohli3 Sept 2021 10:45 AM ISTAdd-on lixisenatide can be used to optimize blood sugar control in Asian individuals with type 2 diabetes unable to achieve their HbA1c glycemic...
Lixisenatide lowers postprandial blood sugar spikes in diabetics after pancreatectomy Dr.Niharika Harsha B30 Jun 2020 10:45 AM ISTLixisenatide, a glucagon-like peptide 1 receptor agonist (GLP-1agonist) effectively reduces postprandial blood sugar excursions in totally...
Sanofi submits new diabetes drug application to US regulator savita thakur thakur24 Dec 2015 10:40 AM ISTParis: French drugmaker Sanofi said it had submitted an application to the US Food and Drug Administration (FDA) for a single daily insulin injection...
